IQV
Price
$252.87
Change
+$0.18 (+0.07%)
Updated
Mar 28, 6:59 PM EST
33 days until earnings call
RGEN
Price
$183.92
Change
-$0.83 (-0.45%)
Updated
Mar 28, 6:59 PM EST
26 days until earnings call
Ad is loading...

Compare predictions IQV vs RGEN

Header iconIQV vs RGEN Comparison
Open Charts IQV vs RGENBanner chart's image
IQVIA Holdings
Price$252.87
Change+$0.18 (+0.07%)
Volume$125.79K
CapitalizationN/A
Repligen
Price$183.92
Change-$0.83 (-0.45%)
Volume$146.99K
CapitalizationN/A
View a ticker or compare two or three
IQV vs RGEN Comparison Chart

Loading...

IQVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RGENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
IQV vs. RGEN commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IQV is a StrongBuy and RGEN is a StrongSell.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (IQV: $252.89 vs. RGEN: $183.70)
Brand notoriety: IQV: Notable vs. RGEN: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IQV: 78% vs. RGEN: 52%
Market capitalization -- IQV: $46.03B vs. RGEN: $10.25B
IQV [@Medical Specialties] is valued at $46.03B. RGEN’s [@Medical Specialties] market capitalization is $10.25B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IQV’s FA Score shows that 2 FA rating(s) are green whileRGEN’s FA Score has 1 green FA rating(s).

  • IQV’s FA Score: 2 green, 3 red.
  • RGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, IQV is a better buy in the long-term than RGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IQV’s TA Score shows that 4 TA indicator(s) are bullish while RGEN’s TA Score has 4 bullish TA indicator(s).

  • IQV’s TA Score: 4 bullish, 4 bearish.
  • RGEN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IQV is a better buy in the short-term than RGEN.

Price Growth

IQV (@Medical Specialties) experienced а -0.66% price change this week, while RGEN (@Medical Specialties) price change was -8.03% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.84%. For the same industry, the average monthly price growth was -0.26%, and the average quarterly price growth was +4.27%.

Reported Earning Dates

IQV is expected to report earnings on May 01, 2024.

RGEN is expected to report earnings on Apr 24, 2024.

Industries' Descriptions

@Medical Specialties (+0.84% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for IQV with price predictions.
OPEN
A.I.dvisor published
a Summary for RGEN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
IQV($46B) has a higher market cap than RGEN($10.2B). RGEN has higher P/E ratio than IQV: RGEN (248.24) vs IQV (34.69). IQV YTD gains are higher at: 9.296 vs. RGEN (2.169). IQV has higher annual earnings (EBITDA): 3.26B vs. RGEN (134M). IQV has more cash in the bank: 1.5B vs. RGEN (751M). RGEN has less debt than IQV: RGEN (712M) vs IQV (13.9B). IQV has higher revenues than RGEN: IQV (15B) vs RGEN (639M).
IQVRGENIQV / RGEN
Capitalization46B10.2B451%
EBITDA3.26B134M2,430%
Gain YTD9.2962.169429%
P/E Ratio34.69248.2414%
Revenue15B639M2,347%
Total Cash1.5B751M199%
Total Debt13.9B712M1,952%
FUNDAMENTALS RATINGS
IQV vs RGEN: Fundamental Ratings
IQV
RGEN
OUTLOOK RATING
1..100
6958
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
2948
SMR RATING
1..100
4388
PRICE GROWTH RATING
1..100
2654
P/E GROWTH RATING
1..100
615
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IQV's Valuation (77) in the Servicestothe Health Industry industry is in the same range as RGEN (90) in the Biotechnology industry. This means that IQV’s stock grew similarly to RGEN’s over the last 12 months.

IQV's Profit vs Risk Rating (29) in the Servicestothe Health Industry industry is in the same range as RGEN (48) in the Biotechnology industry. This means that IQV’s stock grew similarly to RGEN’s over the last 12 months.

IQV's SMR Rating (43) in the Servicestothe Health Industry industry is somewhat better than the same rating for RGEN (88) in the Biotechnology industry. This means that IQV’s stock grew somewhat faster than RGEN’s over the last 12 months.

IQV's Price Growth Rating (26) in the Servicestothe Health Industry industry is in the same range as RGEN (54) in the Biotechnology industry. This means that IQV’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's P/E Growth Rating (5) in the Biotechnology industry is somewhat better than the same rating for IQV (61) in the Servicestothe Health Industry industry. This means that RGEN’s stock grew somewhat faster than IQV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IQVRGEN
RSI
ODDS (%)
Bearish Trend 1 day ago
64%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
72%
MACD
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
58%
Bearish Trend 3 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
IQVDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RGENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DMAR34.900.05
+0.14%
FT Cboe Vest US Equity Deep Bffr ETF Mar
PSCX25.660.03
+0.12%
Pacer Swan SOS Conservative (Jan) ETF
VXUS60.30-0.02
-0.03%
Vanguard Total International Stock ETF
GRNB23.73-0.02
-0.10%
VanEck Green Bond ETF
AWF10.62-0.03
-0.28%
ALLIANCEBERSTEIN GLOBAL HIGH Income FUND

IQV and

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
+0.13%
CRL - IQV
74%
Closely correlated
+0.59%
ICLR - IQV
68%
Closely correlated
+1.96%
TMO - IQV
60%
Loosely correlated
+0.32%
DHR - IQV
59%
Loosely correlated
+0.38%
WAT - IQV
57%
Loosely correlated
-0.28%
More